Lindbrook Capital’s Vaxart VXRT Stock Holding History

Lindbrook Capital’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-402	Closed	-$1K	–	2930
2022 Q2	$1K	Buy	402 +114	+40%	+$426	﹤0.01%	2401
2022 Q1	$1K	Buy	+288	New	+$1.46K	﹤0.01%	2394

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lindbrook Capital's VXRT Position: Q3 2022 in Review

Lindbrook Capital sold out of Vaxart (VXRT) in Q3 2022, closing a stake of 402 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in VXRT in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 143 funds tracked by Wall St. Rank hold VXRT as of Q3 2022.

Lindbrook Capital reported no remaining Vaxart position as of Q3 2022 after selling out during the quarter.
Lindbrook Capital sold 402 Vaxart shares in Q3 2022, an estimated $1K.
Lindbrook Capital first reported a position in Vaxart in Q1 2022 and held it in 2 quarters.
Lindbrook Capital's Vaxart position peaked at $1K in Q2 2022.
143 funds tracked by Wall St. Rank held Vaxart as of Q3 2022.

Based on Lindbrook Capital's 13F filing for Q3 2022, filed 10 Nov 2022.